SYK - Stryker Corp Stock Analysis
Stryker Corp (SYK) is a publicly traded company listed on the NYSE. It operates in the Medical Devices industry, part of the broader Healthcare sector. The company has a market capitalization of 138.52B, generates annual revenue of 24.38B, and reports net income of 2.94B. As of the latest data, the stock is trading at 362.22 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is trading at a high valuation compared to the market average, suggesting investor optimism or growth expectations. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The dividend yield (0.9%) is modest, often associated with growth-oriented companies. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Buy (4.0), indicating current market sentiment. Institutional ownership is reported at 80.64%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -6.43%, trading within a 52-week range of 329.16 - 406.19.
SYK - Stryker Corp
362.22
Analyst Consensus
Buy 4.0
SYK – Analyst Rating Summary
- Strong Buy: 11
- Buy: 15
- Hold: 11
- Sell: 0
- Strong Sell: 0
- Total Analysts: 37
| Index: | S&P 500 | P/E: | 47.56 | EPS (ttm): | 7.62 | Insider Own: | 6.20% | Shs Outstand: | 382.40M | Perf Week: | 1.74% |
| Market Cap: | 138.52B | Forward P/E: | 24.19 | EPS next Y: | 14.97 | Insider Trans: | -2.96% | Shs Float: | 358.69M | Perf Month: | -1.90% |
| Income(ttm): | 2.94B | PEG: | 4.27 | EPS next Q: | 4.39 | Inst Own: | 80.64% | Short Float: | 1.17% | Perf Quarter: | -5.08% |
| Revenue(ttm): | 24.38B | P/S: | 5.68 | EPS this Y: | 11.18% | Inst Trans: | 0.46% | Short Ratio: | 2.92 | Perf Half Y: | -8.11% |
| Book/sh: | 56.97 | P/B: | 6.36 | EPS next Y: | 10.47% | ROA: | 6.48% | Short Interest: | 4.21M | Perf Year: | -6.43% |
| Cash/sh: | 8.74 | P/C: | 41.44 | EPS next 5Y: | 11.15% | ROE: | 14.04% | 52W Range: | 329.16 - 406.19 | Perf YTD: | 0.60% |
| Dividend Est.: | 3.27 (0.90%) | P/FCF: | 34.01 | EPS past 3/5Y: | 14.17% 7.20% | ROIC: | 7.95% | 52W High: | 406.19 -10.82% | Beta: | 0.88 |
| Dividend TTM: | 3.36 (0.93%) | Quick Ratio: | 1.13 | Sales past 3/5Y: | 9.72% 8.71% | Gross Margin: | 62.20% | 52W Low: | 329.16 10.04% | Perf 5Y: | 54.56% |
| Dividend Ex-Date: | Sep 30, 2025 | Current Ratio: | 1.85 | EPS Y/Y TTM: | -18.32% | Oper. Margin: | 22.83% | RSI (14): | 45.61 | Volatility: | 2.46% 2.21% |
| Employees: | 53000 | Debt/Eq: | 0.79 | Sales Y/Y TTM: | 10.95% | Profit Margin: | 12.07% | Recom: | 1.77 | Target Price: | 435.32 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.70 | EPS Q/Q: | 2.70% | Payout: | 41.74% | Rel Volume: | 1.32 | Prev Close: | 373.42 |
| Sales Surprise: | 0.21% | EPS Surprise: | 1.82% | Sales Q/Q: | 10.25% | Earnings: | Oct 30 AMC | Avg Volume: | 1.44M | Price: | 362.22 |
| SMA20: | -1.82% | SMA50: | -2.63% | SMA200: | -4.37% | Undervalued: 20.18% | Volume: | 1,903,528 | Change: | -3.00% | |
Graham Classic formula value: 210.75
(P/E=8 * 1g) Min value: 131.03
(current P/E * 2g) Max value: 478.01
Average value: 273.26
About Stryker Corp
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.